We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+1.09%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$50.8B
AUM Growth
-$294M
(-0.58%)
Cap. Flow
-$328M
Cap. Flow
% of AUM
-0.65%
Top 10 Holdings %
Top 10 Hldgs %
22.21%
Holding
1,137
New
127
Increased
273
Reduced
442
Closed
122
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$255M |
| 2 |
Textron
TXT
|
+$206M |
| 3 |
AstraZeneca
AZN
|
+$164M |
| 4 |
ExxonMobil
XOM
|
+$124M |
| 5 |
Moderna
MRNA
|
+$121M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$962M |
| 2 |
WORK
Slack Technologies, Inc.
WORK
|
+$204M |
| 3 |
Devon Energy
DVN
|
+$201M |
| 4 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$170M |
| 5 |
Carrier Global
CARR
|
+$155M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.3% |
| 2 | Healthcare | 15.98% |
| 3 | Financials | 14.49% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Communication Services | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Gates Industrial Corporation Ltd.
GTES
$7.31B
| $9.52M | 0.02% |
+585,000
| New | +$10M |
|
|
CXP
702
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $9.51M | 0.02% |
+500,000
| New | +$8.7M |
|
703
Kearny Financial
KRNY
$604M
| $9.49M | 0.02% |
763,294
-111,706
| -13% | -$1.38M |
|
704
Savara
SVRA
$1.18B
| $9.47M | 0.02% |
6,864,551
| – | – |
|
705
Lamb Weston
LW
$7.22B
| $9.41M | 0.02% |
153,400
-2,200
| -1% | -$149K |
|
706
Wynn Resorts
WYNN
$10.6B
| $9.37M | 0.02% |
110,600
-1,600
| -1% | -$158K |
|
|
RWT
707
Redwood Trust
RWT
$572M
| $9.31M | 0.02% |
721,965
-324,014
| -31% | -$3.96M |
|
|
PANA
708
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
| $9.28M | 0.02% |
950,000
| – | – |
|
|
AVEO
709
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $9.27M | 0.02% |
1,500,000
+19,000
| +1% | +$114K |
|
710
Ball Corp
BALL
$16.7B
| $9.25M | 0.02% |
102,861
-1,201,026
| -92% | -$107M |
|
|
CORZ
711
DELISTED
Core Scientific, Inc. Common Stock
CORZ
| $9.25M | 0.02% |
914,860
-825,000
| -47% | -$8.29M |
|
712
Molson Coors Class B
TAP
$7.96B
| $9.24M | 0.02% |
199,336
-2,900
| -1% | -$142K |
|
713
DXC Technology
DXC
$1.76B
| $9.22M | 0.02% |
274,278
-3,900
| -1% | -$148K |
|
|
SLN
714
Silence Therapeutics
SLN
$542M
| $9.16M | 0.02% |
444,444
| – | – |
|
715
Teleflex
TFX
$6.14B
| $9.15M | 0.02% |
+24,305
| New | +$9.46M |
|
716
Invesco
IVZ
$14B
| $9.12M | 0.02% |
378,269
-5,300
| -1% | -$133K |
|
717
Black Hills Corp
BKH
$5.6B
| $9.1M | 0.02% |
145,000
+25,000
| +21% | +$1.7M |
|
718
Avnet
AVT
$8.01B
| $9.01M | 0.02% |
243,698
-398,302
| -62% | -$15.7M |
|
|
HRC
719
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $9M | 0.02% |
+60,000
| New | +$8.1M |
|
720
Abeona Therapeutics
ABEO
$394M
| $8.97M | 0.02% |
320,291
| – | – |
|
|
FTEV
721
DELISTED
FinTech Evolution Acquisition Group
FTEV
| $8.96M | 0.02% |
925,000
| – | – |
|
722
Kennametal
KMT
$2.59B
| $8.93M | 0.02% |
261,000
-115,000
| -31% | -$4.13M |
|
|
AMCIU
723
DELISTED
AMCI Acquisition Corp II Units
AMCIU
| $8.93M | 0.02% |
+900,000
| New | +$8.89M |
|
|
VEI
724
DELISTED
Vine Energy Inc.
VEI
| $8.92M | 0.02% |
541,853
-208,414
| -28% | -$3.12M |
|
|
VAPO
725
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $8.91M | 0.02% |
+50,000
| New | +$10.2M |
|
Similar funds
Adage Capital Partners's Q3 2021 Portfolio in Review
As of Q3 2021, Adage Capital Partners held 1,137 positions worth $50.8B, down 0.58% from $51.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Adage Capital Partners's Q3 2021 filing shows 127 new, 273 increased, 442 reduced and 122 closed positions. Its largest new stake was Pfizer: 5,759,101 shares worth $248M. The largest sale was Alexion Pharmaceuticals, an estimated $962M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q3 2021 buy was Pfizer: 5,759,101 shares worth $248M.
- Adage Capital Partners added most to Textron in Q3 2021, an estimated $206M increase.
- Adage Capital Partners's biggest Q3 2021 reduction was Devon Energy, cutting an estimated $201M.
- Adage Capital Partners fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $962M.
- Adage Capital Partners's ten largest holdings make up 22% of its $50.8B portfolio in Q3 2021.
- Adage Capital Partners opened 127 new positions and closed 122 in Q3 2021.
- Adage Capital Partners's portfolio value fell 0.58% quarter-over-quarter to $50.8B.
Based on Adage Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.